Literature DB >> 22452784

Oestrogen causes ATBF1 protein degradation through the oestrogen-responsive E3 ubiquitin ligase EFP.

Xue-Yuan Dong1, Xiaoying Fu, Songqing Fan, Peng Guo, Dan Su, Jin-Tang Dong.   

Abstract

We reported previously that the tumour suppressor ATBF1 (AT motif-binding factor 1) formed an autoregulatory feedback loop with oestrogen-ERα (oestrogen receptor α) signalling to regulate oestrogen-dependent cell proliferation in breast cancer cells. In this loop ATBF1 inhibits the function of oestrogen-ERα signalling, whereas ATBF1 protein levels are fine-tuned by oestrogen-induced transcriptional up-regulation as well as UPP (ubiquitin-proteasome pathway)-mediated protein degradation. In the present study we show that EFP (oestrogen-responsive finger protein) is an E3 ubiquitin ligase mediating oestrogen-induced ATBF1 protein degradation. Knockdown of EFP increases ATBF1 protein levels, whereas overexpression of EFP decreases ATBF1 protein levels. EFP interacts with and ubiquitinates ATBF1 protein. Furthermore, we show that EFP is an important factor in oestrogen-induced ATBF1 protein degradation in which some other factors are also involved. In human primary breast tumours the levels of ATBF1 protein are positively correlated with the levels of EFP protein, as both are directly up-regulated ERα target gene products. However, the ratio of ATBF1 protein to EFP protein is negatively correlated with EFP protein levels. Functionally, ATBF1 antagonizes EFP-mediated cell proliferation. These findings not only establish EFP as the E3 ubiquitin ligase for oestrogen-induced ATBF1 protein degradation, but further support the autoregulatory feedback loop between ATBF1 and oestrogen-ERα signalling and thus implicate ATBF1 in oestrogen-dependent breast development and carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22452784      PMCID: PMC3754848          DOI: 10.1042/BJ20111890

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

Review 1.  Mechanisms underlying ubiquitination.

Authors:  C M Pickart
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

Review 2.  Hormone action in the mammary gland.

Authors:  Cathrin Brisken; Bert O'Malley
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-08-25       Impact factor: 10.005

3.  ATBF1 inhibits estrogen receptor (ER) function by selectively competing with AIB1 for binding to the ER in ER-positive breast cancer cells.

Authors:  Xue-Yuan Dong; Xiaodong Sun; Peng Guo; Qunna Li; Masakiyo Sasahara; Yoko Ishii; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2010-08-18       Impact factor: 5.157

4.  Estrogen up-regulates ATBF1 transcription but causes its protein degradation in estrogen receptor-alpha-positive breast cancer cells.

Authors:  Xue-Yuan Dong; Peng Guo; Xiaodong Sun; Qunna Li; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2011-03-02       Impact factor: 5.157

5.  Efp as a primary estrogen-responsive gene in human breast cancer.

Authors:  K Ikeda; A Orimo; Y Higashi; M Muramatsu; S Inoue
Journal:  FEBS Lett       Date:  2000-04-21       Impact factor: 4.124

6.  Analysis of estrogen-responsive finger protein expression in benign and malignant human breast.

Authors:  S D Thomson; S Ali; L Pickles; J Taylor; P E Pace; M Lymboura; S Shousha; R C Coombes
Journal:  Int J Cancer       Date:  2001-01-15       Impact factor: 7.396

7.  Oestrogen causes degradation of KLF5 by inducing the E3 ubiquitin ligase EFP in ER-positive breast cancer cells.

Authors:  Ke-Wen Zhao; Deepa Sikriwal; Xueyuan Dong; Peng Guo; Xiaodong Sun; Jin-Tang Dong
Journal:  Biochem J       Date:  2011-07-15       Impact factor: 3.857

Review 8.  Role of coactivators and corepressors in steroid and nuclear receptor signaling: potential markers of tumor growth and drug sensitivity.

Authors:  E Cottone; F Orso; N Biglia; P Sismondi; M De Bortoli
Journal:  Int J Biol Markers       Date:  2001 Jul-Sep       Impact factor: 3.248

9.  ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism.

Authors:  Anne-Marie Cleton-Jansen; Ronald van Eijk; Marcel Lombaerts; Marjanka K Schmidt; Laura J Van't Veer; Katja Philippo; Rhyenne M E Zimmerman; Johannes L Peterse; Vincent T B H M Smit; Tom van Wezel; Cees J Cornelisse
Journal:  BMC Cancer       Date:  2008-04-16       Impact factor: 4.430

10.  Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancer.

Authors:  Kazuharu Kai; Zhenhuan Zhang; Hiroko Yamashita; Yutaka Yamamoto; Yutaka Miura; Hirotaka Iwase
Journal:  BMC Cancer       Date:  2008-09-16       Impact factor: 4.430

View more
  14 in total

1.  TRIM25 Is Required for the Antiviral Activity of Zinc Finger Antiviral Protein.

Authors:  Xiaojiao Zheng; Xinlu Wang; Fan Tu; Qin Wang; Zusen Fan; Guangxia Gao
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

2.  SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.

Authors:  Rui Wu; Jiali Fang; Mingcheng Liu; Jun A; Jinming Liu; Wenxuan Chen; Juan Li; Gui Ma; Zhiqian Zhang; Baotong Zhang; Liya Fu; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2020-04-05       Impact factor: 5.157

3.  A complex insertion/deletion polymorphism in the compositionally biased region of the ZFHX3 gene in patients with coronary heart disease in a Chinese population.

Authors:  Shunchang Sun; Wenwu Zhang; Xi Chen; Yunsheng Peng; Qunrong Chen
Journal:  Int J Clin Exp Med       Date:  2015-05-15

4.  Characterization of nuclear localization and SUMOylation of the ATBF1 transcription factor in epithelial cells.

Authors:  Xiaodong Sun; Jie Li; Frederick N Dong; Jin-Tang Dong
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

5.  Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling.

Authors:  Wataru Sato; Kazuhiro Ikeda; Tomohiko Urano; Yayoi Abe; Norie Nakasato; Kuniko Horie-Inoue; Satoru Takeda; Satoshi Inoue
Journal:  PLoS One       Date:  2018-12-26       Impact factor: 3.240

6.  ZFHX3 is indispensable for ERβ to inhibit cell proliferation via MYC downregulation in prostate cancer cells.

Authors:  Qingxia Hu; Baotong Zhang; Rui Chen; Changying Fu; Jun A; Xing Fu; Juan Li; Liya Fu; Zhiqian Zhang; Jin-Tang Dong
Journal:  Oncogenesis       Date:  2019-04-12       Impact factor: 7.485

7.  Atbf1 regulates pubertal mammary gland development likely by inhibiting the pro-proliferative function of estrogen-ER signaling.

Authors:  Mei Li; Xiaoying Fu; Gui Ma; Xiaodong Sun; Xueyuan Dong; Tamas Nagy; Changsheng Xing; Jie Li; Jin-Tang Dong
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

8.  Deletion of atbf1/zfhx3 in mouse prostate causes neoplastic lesions, likely by attenuation of membrane and secretory proteins and multiple signaling pathways.

Authors:  Xiaodong Sun; Xiaoying Fu; Jie Li; Changsheng Xing; Henry F Frierson; Hao Wu; Xiaokun Ding; Tongzhong Ju; Richard D Cummings; Jin-Tang Dong
Journal:  Neoplasia       Date:  2014-06-14       Impact factor: 5.715

9.  The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer.

Authors:  Shan Wang; Rahul K Kollipara; Caroline G Humphries; Shi-Hong Ma; Ryan Hutchinson; Rui Li; Javed Siddiqui; Scott A Tomlins; Ganesh V Raj; Ralf Kittler
Journal:  Oncotarget       Date:  2016-10-04

Review 10.  Sex Hormones in Acquired Immunity and Autoimmune Disease.

Authors:  Vaishali R Moulton
Journal:  Front Immunol       Date:  2018-10-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.